These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 24647144)

  • 21. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
    He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
    Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
    Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
    J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified.
    Javaheri A; Rader DJ
    Circ Res; 2014 May; 114(11):1681-3. PubMed ID: 24855198
    [No Abstract]   [Full Text] [Related]  

  • 25. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.
    Soro-Paavonen A; Naukkarinen J; Lee-Rueckert M; Watanabe H; Rantala E; Soderlund S; Hiukka A; Kovanen PT; Jauhiainen M; Peltonen L; Taskinen MR
    J Lipid Res; 2007 Jun; 48(6):1409-16. PubMed ID: 17372331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
    Zamanian-Daryoush M; Gogonea V; DiDonato AJ; Buffa JA; Choucair I; Levison BS; Hughes RA; Ellington AD; Huang Y; Li XS; DiDonato JA; Hazen SL
    J Biol Chem; 2020 Apr; 295(15):4836-4848. PubMed ID: 32098873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel bioactive lipids enhanced HDL-mediated cholesterol efflux from macrophages through the ABCA1 receptor pathway.
    Khattib A; Shmet M; Ashkar R; Hayek T; Khatib S
    Chem Phys Lipids; 2024 Jan; 258():105367. PubMed ID: 38103770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
    Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
    Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.
    Yvan-Charvet L; Ranalletta M; Wang N; Han S; Terasaka N; Li R; Welch C; Tall AR
    J Clin Invest; 2007 Dec; 117(12):3900-8. PubMed ID: 17992262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.
    Hancock-Cerutti W; Millar JS; Valentini S; Liu J; Billheimer JT; Rader DJ; Cuchel M
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
    Jin Z; Zhou L; Tian R; Lu N
    Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
    Shao B; Pennathur S; Pagani I; Oda MN; Witztum JL; Oram JF; Heinecke JW
    J Biol Chem; 2010 Jun; 285(24):18473-84. PubMed ID: 20378541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I.
    Hossain MA; Ngeth S; Chan T; Oda MN; Francis GA
    BMC Biochem; 2012 Jan; 13():1. PubMed ID: 22248050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.
    Patel PJ; Khera AV; Wilensky RL; Rader DJ
    Eur J Heart Fail; 2013 Nov; 15(11):1215-9. PubMed ID: 23709232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
    Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
    Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
    Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
    Khera AV; Cuchel M; de la Llera-Moya M; Rodrigues A; Burke MF; Jafri K; French BC; Phillips JA; Mucksavage ML; Wilensky RL; Mohler ER; Rothblat GH; Rader DJ
    N Engl J Med; 2011 Jan; 364(2):127-35. PubMed ID: 21226578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current models of apolipoprotein A-I lipidation by adenosine triphosphate binding cassette transporter A1.
    Hafiane A; Gianopoulos I; Sorci-Thomas MG; Daskalopoulou SS
    Curr Opin Lipidol; 2022 Apr; 33(2):139-145. PubMed ID: 34581311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.